Medicare GLP-1 Bridge: Expanding Access to Weight-Loss Medications
Discover how the Medicare GLP-1 Bridge enhances access to weight-loss medications for Medicare beneficiaries, impacting eligibility and reimbursement practices.
Discover how the Medicare GLP-1 Bridge enhances access to weight-loss medications for Medicare beneficiaries, impacting eligibility and reimbursement practices.
Discover the new GLP-1 Bridge Program under Medicare providing access to weight-loss medications for a monthly fee. Simplify your prescription experience today!
Explore the ongoing legal challenge between insurers and pharmacies over opioid-related claims in Georgia and Florida, with potential impacts on financial responsibilities.
Explore the evolution of pharmacies into vital healthcare providers and the strategies for improving patient engagement and outcomes through digital transformation.
Blue Shield of California appoints Hayley Park as Chief Pharmacy Officer to enhance medication access and affordability, fostering patient-centered care.
Explore the Trump administration's proposal on MFN agreements affecting pharmaceutical pricing and the ongoing regulatory developments in healthcare.
Explore key legislative changes in Kansas impacting health policy and the insurance industry, including Medicaid reforms and new pharmacist roles. Stay informed!
Medicare Part D reimbursement changes risk closure of 60% of Arizona's long-term care pharmacies, impacting medication access for thousands of elderly Medicare beneficiaries. Legislative and administrative actions are being proposed to address the crisis.
Independent U.S. pharmacies leverage Medicare Advantage OTC benefits to diversify revenue and enhance patient care amid rising healthcare costs and reimbursement challenges.
Michigan pharmacist sentenced to 46 months for $4M Medicare fraud involving phantom prescriptions. DOJ Health Care Fraud Strike Force prosecuted the case.